2NE1 Park Bom’s Latest Update Following Drug Abuse Accusations Against Sandara Park Catches Attention
2NE1 member Park Bom shared an update on her recent status through a selfie.
On March 6, Park Bom posted a photo on her social media account with the brief caption “Park Bom♥.”
In the photo, Park Bom stares at the camera with makeup emphasizing her eyes and lips.
This post drew even more attention as it was her first selfie released since the recent controversy. Earlier, Park Bom had shared a handwritten letter claiming, “Sandara Park got caught for drugs, and to cover that up, they made Park Bom look like a drug user,” which caused a stir.
2NE1’s Park Bom Shockingly Claims She Was Framed To Cover Up Sandara Park’s Drug Abuse
In response, Sandara Park dismissed the allegations with a statement saying, “I have never used drugs. I wish her well.”
2NE1’s Sandara Park Personally Posts About Park Bom’s Drug Use Allegations
Currently, Park Bom is on hiatus due to health issues and is taking a break from activities. Fans are increasingly concerned as Park Bom, known to be emotionally unstable, continues to display erratic behavior.
Among netizens, there have been messages of support such as “Park Bom needs help,” “I hope she pauses and rests enough,” and “I hope she eats well, sleeps well, and finds happiness.”
In 2010, Park Bom was caught by customs for importing the prescription drug Adderall via international express delivery from the United States but received a suspension of indictment in 2014 as it was recognized to be for treatment purposes.
In 2019, Park Bom’s agency explained the past drug controversy by stating, “Adderall is a legally prescribed medicine approved by the U.S. FDA, and the incident occurred due to a lack of proper awareness of domestic regulations,” and apologized again, saying, “We are sorry for the trouble caused by actions resulting from ignorance.” The agency also added that Park Bom has ADD (Attention Deficit Disorder) and has been receiving consistent treatment at a university hospital in Korea.